Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade F 1.22 0.83% 0.01
AYTU closed up 0.83 percent on Tuesday, October 15, 2019, on 41 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical AYTU trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 0.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.83%
MACD Bullish Signal Line Cross Bullish 0.83%
Wide Bands Range Expansion 0.83%
20 DMA Resistance Bearish 0.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.83%
Wide Bands Range Expansion 0.83%
Up 3 Days in a Row Strength 0.83%

Older signals for AYTU ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Healthcare Organ Systems Prostate Cancer Alcohols Hormones Ketones Company's Pipeline Urinary Tract Infections Androstanes Male Infertility Testosterone
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.61
52 Week Low 0.68
Average Volume 116,871
200-Day Moving Average 1.526
50-Day Moving Average 1.3112
20-Day Moving Average 1.2151
10-Day Moving Average 1.0971
Average True Range 0.1256
ADX 21.15
+DI 20.9179
-DI 19.6326
Chandelier Exit (Long, 3 ATRs ) 1.1632
Chandelier Exit (Short, 3 ATRs ) 1.2868
Upper Bollinger Band 1.5098
Lower Bollinger Band 0.9204
Percent B (%b) 0.51
BandWidth 48.506296
MACD Line -0.0656
MACD Signal Line -0.0775
MACD Histogram 0.0119
Fundamentals Value
Market Cap 4.91 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.03
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.40
Resistance 3 (R3) 1.40 1.33 1.37
Resistance 2 (R2) 1.33 1.29 1.34 1.36
Resistance 1 (R1) 1.28 1.26 1.25 1.28 1.35
Pivot Point 1.21 1.21 1.20 1.22 1.21
Support 1 (S1) 1.16 1.17 1.13 1.16 1.09
Support 2 (S2) 1.09 1.14 1.10 1.08
Support 3 (S3) 1.04 1.09 1.07
Support 4 (S4) 1.04